新型咪唑-查尔酮衍生物的设计、合成及抗宫颈癌和顺铂耐药活性研究

摘要 目的 以甘草查尔酮母核为先导化合物骨架,设计、合成一系列新型咪唑-查尔酮衍生物并进行抗宫颈癌活性研究。方法 在查尔酮骨架的B环引入4种咪唑环,在A环分别引入甲氧基、氨基、羟基等活性基团;采用Claisen-Schmidt反应合成系列新型咪唑-查尔酮衍生物,其结构经1H-NMR、13C-NMR和HRMS进行表征。通过MTT、Transwell、流式细胞仪和分子对接实验方法,初步探索目标化合物的抗宫颈癌活性及作用机制。结果 大部分化合物具有一定的抗宫颈癌活性,其中2i较为显著,且对正常细胞的毒性较小。此外,化合物2i能够显著抑制HeLa和HeLa/DDP细胞的迁移和侵袭能力,能够诱导其凋亡,并阻滞HeLa和HeLa/DDP细胞于G2/M期;分子对接模拟显示2i与查尔酮母核和原配体秋水仙碱相比,2i与微管蛋白秋水仙碱结合位点具有较好的结合能力,并能够产生氢键相互作用力。结论 化合物2i具有较显著的抗宫颈癌和抗宫颈癌顺铂耐药活性作用,这可能与其抑制了微管蛋白靶点有关。     

新型查尔酮哌嗪衍生物的合成

以4-二甲氨基苯甲醛和2-溴-4′-氟苯乙酮为原料,经缩合和取代反应制得4-二甲氨基-4′-(1-哌嗪基)查尔酮(2); 2与卤代烃反应合成了6个新型的查尔酮哌嗪衍生物,收率71%~88%,其结构经¹H NMR,¹³C NMR和HR-MS表征。     

Unexpected detection of 3‐aroylbenzofuran side products in the preparation of 2‐arylbenzofurans: Identification,characterization, and comparison with chalcone's fragmentation patterns using EI/MSn

A gas chromatography‐mass spectrometry study of the intramolecular Wittig reaction revealed, together with the expected 2‐phenylbenzofuran, the formation of an unexpected side product that has not been reported until now. This study reports the identification of the by‐product, ie, the 3‐benzoyl‐2‐phenylbenzofuran, on the base of its mass spectrometric behaviour using a combination of electron ionization, exact mass measurement, multiple stage mass spectrometry, and labelled compounds. This study reports the common fragmentation pathways and discusses possible fragment structures of characteristic ions from a series of 3‐aroyl‐2‐arylbenzofuran derivatives obtained as by‐product under Wittig conditions. Emphasis is laid on the formation and structure investigation of the [M‐H]⁺ and [M‐OH]⁺ ions. Our results showed interesting analogies with the mass spectrometric behaviour of chalcones.     

超声波和无溶剂条件下1-芳基-5-二茂铁基-1,4-二烯-3-酮的合成

在室温下使用超声波或无溶剂条件下,4-二茂铁基-3-烯-2-酮和芳香醛的羟醛缩合能以83％～97％的收率得到1-芳基-5-二茂铁基-1,4-二烯3-酮。这种方法具有操作简单,反应条件温和,产率高和低能耗等优点。     

Panduratin A Derivative Protects against Cisplatin-Induced Apoptosis of Renal Proximal Tubular Cells and Kidney Injury in Mice

Background: Panduratin A is a bioactive cyclohexanyl chalcone exhibiting several pharmacological activities, such as anti-inflammatory, anti-oxidative, and anti-cancer activities. Recently, the nephroprotective effect of panduratin A in cisplatin (CDDP) treatment was revealed. The present study examined the potential of certain compounds derived from panduratin A to protect against CDDP-induced nephrotoxicity. Methods: Three derivatives of panduratin A (DD-217, DD-218, and DD-219) were semi-synthesized from panduratin A. We investigated the effects and corresponding mechanisms of the derivatives of panduratin A for preventing nephrotoxicity of CDDP in both immortalized human renal proximal tubular cells (RPTEC/TERT1 cells) and mice. Results: Treating the cell with 10 µM panduratin A significantly reduced the viability of RPTEC/TERT1 cells compared to control (panduratin A: 72% ± 4.85%). Interestingly, DD-217, DD-218, and DD-219 at the same concentration did not significantly affect cell viability (92% ± 8.44%, 90% ± 7.50%, and 87 ± 5.2%, respectively). Among those derivatives, DD-218 exhibited the most protective effect against CDDP-induced renal proximal tubular cell apoptosis (control: 57% ± 1.23%; DD-218: 19% ± 10.14%; DD-219: 33% ± 14.06%). The cytoprotective effect of DD-218 was mediated via decreases in CDDP-induced mitochondria dysfunction, intracellular reactive oxygen species (ROS) generation, activation of ERK1/2, and cleaved-caspase 3 and 7. In addition, DD-218 attenuated CDDP-induced nephrotoxicity by a decrease in renal injury and improved in renal dysfunction in C57BL/6 mice. Importantly, DD-218 did not attenuate the anti-cancer efficacy of CDDP in non-small-cell lung cancer cells or colon cancer cells. Conclusions: This finding suggests that DD-218, a derivative of panduratin A, holds promise as an adjuvant therapy in patients receiving CDDP.     

SOCl2/EtOH催化查尔酮的合成

查尔酮类化合物具有多种药理作用和生物活性,同时它也是一种新型的有机非线性光学材料。经典的合成方法是使用强碱或者强酸催化苯乙酮和苯甲醛的羟醛缩合,但是副反应较多,产率偏低。近期也有文献报道使用有机碲氧化物和KF-Al2O3等试剂或者使用超声波、固相合成和微波等方法合成查尔酮。本文使用     

一种支链含有螺吡喃和查尔酮双光功能基团的复合高分子材料光致变色性能研究

合成了两种支链含有光致变色的螺吡喃结构的复合高分子材料, 观察了光激发下材料的光致变色动力学过程. 一种高分子材料为丙烯酸甲脂(MMA)和丙烯酸-螺吡喃单体(MMA-Spiropyran)的共聚物, 另一种是丙烯酸-查尔酮单体(MMA-Chalcone)和丙烯酸-螺吡喃单体的共聚物. 利用紫外-可见光谱仪对合成的复合高分子材料的光敏性能进行了考察, 从研究中发现, 材料的光致聚合过程对其光致变色显色体稳定性的影响.     

微波干法合成查尔酮

查尔酮的化学名为1,3-二苯基丙烯酮,以它为母体的天然化合物存在于红花、甘草等多种天然植物中,是植物体内合成黄烷酮的重要中间体,其自身也具有抗过敏、抗溃疡、抗肿瘤等药理作用[1-3].     

由2',4'-二氢-6'-甲氧基-3',5'-二甲基查耳酮合成新黄酮

在DMSO/ I2的氧化作用下,由2',4'-二氢-6'-甲氧基-3',5'-二甲基查耳酮可合成一种全新结构的黄酮:7-羟基-5-甲氧基-6,8-二甲基黄酮(产率91%),而在HCl/MeOH作用下则得到了两种黄烷酮:7-羟基-5-甲氧基-6,8-二甲基黄烷酮 (产率70%) 和 5,7-二羟基-6,8-二甲基黄烷酮 (产率20%).